SELLAS Life Sciences (SLS) is rated 'Hold' due to pending phase 3 REGAL data for GPS in AML after CR2, a major 2026 catalyst.
ImmunoScape presented compelling new preclinical data at the American Association for Cancer Research (AACR) Annual Meeting 2026.
Researchers have introduced a platform to analyze heart fibroblast behavior, revealing pathways involved in fibrosis and ...
Fibroblasts are an essential component of the heart, as they play key roles in its structure, development and response to ...
Fibroblasts are an essential component of the heart, as they play key roles in its structure, development and response to ...
Fibroblasts are an essential component of the heart, as they play key roles in its structure, development and response to ...
Sellas Life Sciences Group Inc. (NASDAQ:SLS) is one of the best healthcare penny stocks to buy according to hedge funds. On ...
Clover Health Investments, Corp. (NASDAQ:CLOV) is one of the best healthcare penny stocks to buy according to hedge funds. On ...
Acute myeloid leukemia (AML) has a poor prognosis, especially in elderly and relapsed/refractory patients, with 5‑year survival below 30% ...
This is a useful study that seeks to elucidate the molecular mechanisms underlying spinal motor circuit assembly. The authors demonstrate that loss of Onecut transcription factors in spinal motor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results